June 02, 2025

New COVID Vaccine Approved for High-Risk Groups

After showing higher efficacy and a comparable safety profile to Spikevax, the FDA has approved Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk patients.

Conexiant

May 30, 2025

CDC Holds Line on Kids' COVID Shots

Despite contrary claims, the CDC still recommends COVID-19 vaccines for healthy children in its latest immunization schedule.

Reuters

May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 27, 2025

COVID Vaccine: CDC Shakes Up Recommendations

U.S. health officials have dropped routine COVID-19 vaccine recommendations for healthy children and pregnant women, signaling a major policy shift.

Reuters

May 23, 2025

JAK Inhibitors Prove Best for COVID

A global analysis finds JAK inhibitors significantly reduce COVID-19 deaths and ventilation needs in hospitalized patients, outperforming other therapies.

Reuters

May 22, 2025

FDA to Rethink COVID Booster Formula

FDA advisers to vote on whether 2025–2026 COVID vaccines should target JN.1 descendants like LP.8.1 amid rising uncertainty over dominant strains.

Reuters

May 22, 2025

Dual Inhaler Halves Mild Asthma Attacks in Trial

As-needed albuterol-budesonide was superior to albuterol alone for mild, uncontrolled asthma in new trial.

Conexiant

May 21, 2025

Pregnancy Linked to Lower Long COVID Risk

New research analyzing over 72,000 pregnant COVID-19 patients reveals they face a significantly reduced risk of developing long-term symptoms compared to nonpregnant women, with key risk factors identified across both cohorts.

Conexiant

May 20, 2025

New COVID Shot: LP.8.1?

FDA advisers to consider recommending COVID-19 vaccine for 2025-2026 season to target LP.8.1 subvariant.

Reuters